SFM
PDSB icon

Sphera Funds Management’s PDS Biotechnology PDSB Stock Holding History

Sphera Funds Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,687
Closed -$3.13M – 133
2017
Q4 		$3.13M Hold
16,687
– – 0.37% 68
2017
Q3 		$3.58M Buy
16,687
+9,187
+122% +$1.9M 0.51% 54
2017
Q2 		$1.54M Hold
7,500
– – 0.26% 95
2017
Q1 		$1.37M Hold
7,500
– – 0.27% 86
2016
Q4 		$1.88M Hold
7,500
– – 0.47% 60
2016
Q3 		$1.56M Hold
7,500
– – 0.25% 82
2016
Q2 		$1.52M Hold
7,500
– – 0.39% 66
2016
Q1 		$1.37M Sell
7,500
-250
-3% -$44.7K 0.3% 72
2015
Q4 		$1.94M Buy
+7,750
New +$2.5M 0.28% 87

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sphera Funds Management's PDSB Position: Q1 2018 in Review

Sphera Funds Management sold out of PDS Biotechnology (PDSB) in Q1 2018, closing a stake of 16,687 shares — an estimated $3.13M sold.

Sphera Funds Management first reported a position in PDSB in Q4 2015 and held it in 9 quarters. The position peaked at $3.58M in Q3 2017. 60 funds tracked by Wall St. Rank hold PDSB as of Q1 2018.

  • Sphera Funds Management reported no remaining PDS Biotechnology position as of Q1 2018 after selling out during the quarter.
  • Sphera Funds Management sold 16,687 PDS Biotechnology shares in Q1 2018, an estimated $3.13M.
  • Sphera Funds Management first reported a position in PDS Biotechnology in Q4 2015 and held it in 9 quarters.
  • Sphera Funds Management's PDS Biotechnology position peaked at $3.58M in Q3 2017.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.